Literature DB >> 14000519

Effect of mercaptoethanol on complement binding ability of human 7 S gammaglobulin.

G WIEDERMANN, P A MIESCHER, E C FRANKLIN.   

Abstract

Entities:  

Keywords:  COMPLEMENT; GAMMA GLOBULIN; SULFHYDRYL COMPOUNDS

Mesh：

Substances：

Year:  1963        PMID： 14000519     DOI： 10.3181/00379727-113-28440

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  30 in total

1.  A study of complement fixation by rheumatoid factor using a haemolytic assay system.

Authors:  M M Taylor-Upsahl; P M Johnson; O J Mellbye; J B Natvig
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

2.  Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease.

Authors:  R H Zubler; U Nydegger; L H Perrin; K Fehr; J McCormick; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

3.  C1q binding substances in pemphigus and bullous pemphigoid. Detection with a [131I] C1q binding assay.

Authors:  G Tappeiner; K G Heine; J C Kahl; R E Jordon
Journal:  Clin Exp Immunol       Date:  1977-04       Impact factor: 4.330

4.  Developed M haemolytic plaque-forming cells in chickens.

Authors:  F L Shand; J Ivanyi
Journal:  Immunology       Date:  1973-04       Impact factor: 7.397

5.  The influence of Bordetella pertussis on the kinetics of antibody production to sheep red blood cells in NMRI mice.

Authors:  H Finger; P Emmerling
Journal:  Experientia       Date:  1968-08-15

6.  Phagocytosis in subacute bacterial endocarditis. Localization of the primary opsonic site to Fc fragment.

Authors:  P G Quie; R P Messner; R C Williams
Journal:  J Exp Med       Date:  1968-10-01       Impact factor: 14.307

7.  Rheumatoid factor plaque-forming cells in rheumatoid synovial tissue.

Authors:  M M Taylor-Upsahl; T G Abrahamsen; J B Natvig
Journal:  Clin Exp Immunol       Date:  1977-05       Impact factor: 4.330

8.  Circulating antibody response in BCG vaccination, tuberculous infection and sarcoidosis.

Authors:  R Wallace; B B Diena; A G Jessamine; L Greenberg
Journal:  Can Med Assoc J       Date:  1967-03-11       Impact factor: 8.262

9.  Breakdown products of C 3 in human synovial fluids.

Authors:  N J Zvaifler
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

10.  Novel siRNA delivery system to target podocytes in vivo.

Authors:  Peter V Hauser; Jeffrey W Pippin; Cora Kaiser; Ronald D Krofft; Paul T Brinkkoetter; Kelly L Hudkins; Dontscho Kerjaschki; Jochen Reiser; Charles E Alpers; Stuart J Shankland
Journal:  PLoS One       Date:  2010-03-01       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.